In this issue:
- Fertility with BrECADD or eBEACOPP for advanced stage classical Hodgkin lymphoma
- Cyclophosphamide and ciclosporin for GVHD prophylaxis
- Enhanced CAR T-cell therapy for lymphoma after failure
- Acalabrutinib + bendamustine-rituximab in untreated MCL
- Isatuximab + cemiplimab for relapsed/refractory ENKTL
- Disease risk, not remission, determines transplant outcomes in AML
- Trends in AL amyloidosis
- Adding venetoclax to bortezomib and dexamethasone in relapsed/refractory MM
- Belantamab mafodotin bortezomib-dexamethasone in relapsed/refractory MM
- Isatuximab-carfilzomib lenalidomide-dexamethasone induction in newly diagnosed MM
Please login below to download this issue (PDF)